According to the research report, the global market for Oncology Nutrition Deals should grow from US$ 1260 million in 2022 to US$ 2723.9 million by 2029, with a CAGR of 11.6% for the period of 2023-2029.
The rising incidence of cancer and increasing expenditure on healthcare due to changing lifestyles are expected to drive the growth of this market. Moreover, increasing investment in research and continuous development in technology and treatment are opportunities for players operating in the oncology nutrition market. On the other hand, a lack of knowledge and understanding regarding oncology nutrition can hinder its growth.
Oncology nutrition deals with managing the nutritional intake of patients suffering from cancer to support the treatment and reduce its side effects. The oncology nutrition market can be classified based on the type of cancer, which includes lung cancer, head and neck cancer, stomach cancers, liver cancer, blood cancer, and others; by nutrition, including enteral nutrition and parenteral nutrition.
This report studies and analyses global Oncology Nutrition Deals status and future trends, to help determine the Oncology Nutrition Deals market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Oncology Nutrition Deals, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Oncology Nutrition Deals market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)
(2) Global Oncology Nutrition Deals by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(3) China Oncology Nutrition Deals by company, revenue, market share and industry ranking 2018-2023, (US$ million)
(4) Global Oncology Nutrition Deals key consuming regions, consumption value and demand structure
(5) Oncology Nutrition Deals industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Abbott Laboratories
Ajinomoto Cambrooke
Aceto
American Society for Parenteral and Enteral Nutrition (ASPEN)
Baxter
Danone Nutricia
Fresenius Kabi AG
FMC Corporation
Global Health Products, Inc
Koninklijke DSM N.V.
Mead Johnson & Company, LLC
Nestle Health Science
Smartfish AS
Market segment by Type, covers
Enteral Nutrition
Parenteral Nutrition
Market segment by Application, can be divided into
Hospitals
Homecare
Specialty Clinics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Oncology Nutrition Deals product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Oncology Nutrition Deals market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 3: China Oncology Nutrition Deals market share and ranking of major manufacturers, revenue, 2018-2023
Chapter 4: Oncology Nutrition Deals industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
1 Market Overview
1.1 Oncology Nutrition Deals Definition
1.2 Global Oncology Nutrition Deals Market Size and Forecast
1.3 China Oncology Nutrition Deals Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Oncology Nutrition Deals Market Size: China VS Global Growth Rate, 2018-2029
1.6 Oncology Nutrition Deals Market Dynamics
1.6.1 Oncology Nutrition Deals Market Drivers
1.6.2 Oncology Nutrition Deals Market Restraints
1.6.3 Oncology Nutrition Deals Industry Trends
1.6.4 Oncology Nutrition Deals Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Oncology Nutrition Deals, Global Market Share by Company, 2018-2023
2.2 Global Oncology Nutrition Deals Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Oncology Nutrition Deals Concentration Ratio
2.4 Global Oncology Nutrition Deals Mergers & Acquisitions, Expansion Plans
2.5 Global Oncology Nutrition Deals Major Companies Product Type
2.6 Head Office and Oncology Nutrition Deals Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Oncology Nutrition Deals, China Market Share by Company, 2018-2023
3.2 China Oncology Nutrition Deals Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Oncology Nutrition Deals Industry Chain
4.2 Oncology Nutrition Deals Upstream Analysis
4.2.1 Oncology Nutrition Deals Core Raw Materials
4.2.2 Main Manufacturers of Oncology Nutrition Deals Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Oncology Nutrition Deals Production Mode
4.6 Oncology Nutrition Deals Procurement Model
4.7 Oncology Nutrition Deals Industry Sales Model and Sales Channels
4.7.1 Oncology Nutrition Deals Sales Model
4.7.2 Oncology Nutrition Deals Typical Distributors
5 Sights by Type
5.1 Oncology Nutrition Deals Classification
5.1.1 Enteral Nutrition
5.1.2 Parenteral Nutrition
5.2 By Type, Global Oncology Nutrition Deals Consumption Value & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Oncology Nutrition Deals Consumption Value, 2018-2029
6 Sights by Application
6.1 Oncology Nutrition Deals Segment by Application
6.1.1 Hospitals
6.1.2 Homecare
6.1.3 Specialty Clinics
6.2 By Application, Global Oncology Nutrition Deals Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Oncology Nutrition Deals Consumption Value, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Oncology Nutrition Deals Consumption Value, 2018 VS 2022 VS 2029
7.2 By Region, Global Oncology Nutrition Deals Consumption Value, 2018-2029
7.3 North America
7.3.1 North America Oncology Nutrition Deals & Forecasts, 2018-2029
7.3.2 By Country, North America Oncology Nutrition Deals Market Size Market Share
7.4 Europe
7.4.1 Europe Oncology Nutrition Deals Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Oncology Nutrition Deals Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Oncology Nutrition Deals Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Oncology Nutrition Deals Market Size Market Share
7.6 South America
7.6.1 South America Oncology Nutrition Deals Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Oncology Nutrition Deals Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Oncology Nutrition Deals Market Size & CAGR, 2018 VS 2022 VS 2029
8.2 By Country, Global Oncology Nutrition Deals Consumption Value, 2018-2029
8.3 U.S.
8.3.1 U.S. Oncology Nutrition Deals Market Size, 2018-2029
8.3.2 By Type, U.S. Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.3.3 By Application, U.S. Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Oncology Nutrition Deals Market Size, 2018-2029
8.4.2 By Type, Europe Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.4.3 By Application, Europe Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.5 China
8.5.1 China Oncology Nutrition Deals Market Size, 2018-2029
8.5.2 By Type, China Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.5.3 By Application, China Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Oncology Nutrition Deals Market Size, 2018-2029
8.6.2 By Type, Japan Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.6.3 By Application, Japan Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Oncology Nutrition Deals Market Size, 2018-2029
8.7.2 By Type, South Korea Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.7.3 By Application, South Korea Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Oncology Nutrition Deals Market Size, 2018-2029
8.8.2 By Type, Southeast Asia Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.8.3 By Application, Southeast Asia Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.9 India
8.9.1 India Oncology Nutrition Deals Market Size, 2018-2029
8.9.2 By Type, India Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.9.3 By Application, India Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.10 Middle East & Africa
8.10.1 Middle East & Africa Oncology Nutrition Deals Market Size, 2018-2029
8.10.2 By Type, Middle East & Africa Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
8.10.3 By Application, Middle East & Africa Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
9 Company Profile
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
9.1.2 Abbott Laboratories Company Profile and Main Business
9.1.3 Abbott Laboratories Oncology Nutrition Deals Models, Specifications and Application
9.1.4 Abbott Laboratories Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.1.5 Abbott Laboratories Recent Developments
9.2 Ajinomoto Cambrooke
9.2.1 Ajinomoto Cambrooke Company Information, Head Office, Market Area and Industry Position
9.2.2 Ajinomoto Cambrooke Company Profile and Main Business
9.2.3 Ajinomoto Cambrooke Oncology Nutrition Deals Models, Specifications and Application
9.2.4 Ajinomoto Cambrooke Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.2.5 Ajinomoto Cambrooke Recent Developments
9.3 Aceto
9.3.1 Aceto Company Information, Head Office, Market Area and Industry Position
9.3.2 Aceto Company Profile and Main Business
9.3.3 Aceto Oncology Nutrition Deals Models, Specifications and Application
9.3.4 Aceto Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.3.5 Aceto Recent Developments
9.4 American Society for Parenteral and Enteral Nutrition (ASPEN)
9.4.1 American Society for Parenteral and Enteral Nutrition (ASPEN) Company Information, Head Office, Market Area and Industry Position
9.4.2 American Society for Parenteral and Enteral Nutrition (ASPEN) Company Profile and Main Business
9.4.3 American Society for Parenteral and Enteral Nutrition (ASPEN) Oncology Nutrition Deals Models, Specifications and Application
9.4.4 American Society for Parenteral and Enteral Nutrition (ASPEN) Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.4.5 American Society for Parenteral and Enteral Nutrition (ASPEN) Recent Developments
9.5 Baxter
9.5.1 Baxter Company Information, Head Office, Market Area and Industry Position
9.5.2 Baxter Company Profile and Main Business
9.5.3 Baxter Oncology Nutrition Deals Models, Specifications and Application
9.5.4 Baxter Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.5.5 Baxter Recent Developments
9.6 Danone Nutricia
9.6.1 Danone Nutricia Company Information, Head Office, Market Area and Industry Position
9.6.2 Danone Nutricia Company Profile and Main Business
9.6.3 Danone Nutricia Oncology Nutrition Deals Models, Specifications and Application
9.6.4 Danone Nutricia Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.6.5 Danone Nutricia Recent Developments
9.7 Fresenius Kabi AG
9.7.1 Fresenius Kabi AG Company Information, Head Office, Market Area and Industry Position
9.7.2 Fresenius Kabi AG Company Profile and Main Business
9.7.3 Fresenius Kabi AG Oncology Nutrition Deals Models, Specifications and Application
9.7.4 Fresenius Kabi AG Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.7.5 Fresenius Kabi AG Recent Developments
9.8 FMC Corporation
9.8.1 FMC Corporation Company Information, Head Office, Market Area and Industry Position
9.8.2 FMC Corporation Company Profile and Main Business
9.8.3 FMC Corporation Oncology Nutrition Deals Models, Specifications and Application
9.8.4 FMC Corporation Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.8.5 FMC Corporation Recent Developments
9.9 Global Health Products, Inc
9.9.1 Global Health Products, Inc Company Information, Head Office, Market Area and Industry Position
9.9.2 Global Health Products, Inc Company Profile and Main Business
9.9.3 Global Health Products, Inc Oncology Nutrition Deals Models, Specifications and Application
9.9.4 Global Health Products, Inc Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.9.5 Global Health Products, Inc Recent Developments
9.10 Koninklijke DSM N.V.
9.10.1 Koninklijke DSM N.V. Company Information, Head Office, Market Area and Industry Position
9.10.2 Koninklijke DSM N.V. Company Profile and Main Business
9.10.3 Koninklijke DSM N.V. Oncology Nutrition Deals Models, Specifications and Application
9.10.4 Koninklijke DSM N.V. Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.10.5 Koninklijke DSM N.V. Recent Developments
9.11 Mead Johnson & Company, LLC
9.11.1 Mead Johnson & Company, LLC Company Information, Head Office, Market Area and Industry Position
9.11.2 Mead Johnson & Company, LLC Company Profile and Main Business
9.11.3 Mead Johnson & Company, LLC Oncology Nutrition Deals Models, Specifications and Application
9.11.4 Mead Johnson & Company, LLC Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.11.5 Mead Johnson & Company, LLC Recent Developments
9.12 Nestle Health Science
9.12.1 Nestle Health Science Company Information, Head Office, Market Area and Industry Position
9.12.2 Nestle Health Science Company Profile and Main Business
9.12.3 Nestle Health Science Oncology Nutrition Deals Models, Specifications and Application
9.12.4 Nestle Health Science Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.12.5 Nestle Health Science Recent Developments
9.13 Smartfish AS
9.13.1 Smartfish AS Company Information, Head Office, Market Area and Industry Position
9.13.2 Smartfish AS Company Profile and Main Business
9.13.3 Smartfish AS Oncology Nutrition Deals Models, Specifications and Application
9.13.4 Smartfish AS Oncology Nutrition Deals Revenue and Gross Margin, 2018-2023
9.13.5 Smartfish AS Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Oncology Nutrition Deals Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Oncology Nutrition Deals Market Restraints
Table 3. Oncology Nutrition Deals Market Trends
Table 4. Oncology Nutrition Deals Industry Policy
Table 5. Global Oncology Nutrition Deals Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Oncology Nutrition Deals Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Oncology Nutrition Deals Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Oncology Nutrition Deals Mergers & Acquisitions, Expansion Plans
Table 9. Global Oncology Nutrition Deals Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Oncology Nutrition Deals Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Oncology Nutrition Deals Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Oncology Nutrition Deals Upstream (Raw Materials)
Table 14. Global Oncology Nutrition Deals Typical Customers
Table 15. Oncology Nutrition Deals Typical Distributors
Table 16. By Type, Global Oncology Nutrition Deals Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Oncology Nutrition Deals Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Oncology Nutrition Deals Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Oncology Nutrition Deals Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Oncology Nutrition Deals Consumption Value Market Share, 2018-2029
Table 23. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position
Table 24. Abbott Laboratories Company Profile and Main Business
Table 25. Abbott Laboratories Oncology Nutrition Deals Models, Specifications, and Application
Table 26. Abbott Laboratories Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Abbott Laboratories Recent Developments
Table 28. Ajinomoto Cambrooke Company Information, Head Office, Market Area and Industry Position
Table 29. Ajinomoto Cambrooke Company Profile and Main Business
Table 30. Ajinomoto Cambrooke Oncology Nutrition Deals Models, Specifications, and Application
Table 31. Ajinomoto Cambrooke Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Ajinomoto Cambrooke Recent Developments
Table 33. Aceto Company Information, Head Office, Market Area and Industry Position
Table 34. Aceto Company Profile and Main Business
Table 35. Aceto Oncology Nutrition Deals Models, Specifications, and Application
Table 36. Aceto Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Aceto Recent Developments
Table 38. American Society for Parenteral and Enteral Nutrition (ASPEN) Company Information, Head Office, Market Area and Industry Position
Table 39. American Society for Parenteral and Enteral Nutrition (ASPEN) Company Profile and Main Business
Table 40. American Society for Parenteral and Enteral Nutrition (ASPEN) Oncology Nutrition Deals Models, Specifications, and Application
Table 41. American Society for Parenteral and Enteral Nutrition (ASPEN) Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. American Society for Parenteral and Enteral Nutrition (ASPEN) Recent Developments
Table 43. Baxter Company Information, Head Office, Market Area and Industry Position
Table 44. Baxter Company Profile and Main Business
Table 45. Baxter Oncology Nutrition Deals Models, Specifications, and Application
Table 46. Baxter Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Baxter Recent Developments
Table 48. Danone Nutricia Company Information, Head Office, Market Area and Industry Position
Table 49. Danone Nutricia Company Profile and Main Business
Table 50. Danone Nutricia Oncology Nutrition Deals Models, Specifications, and Application
Table 51. Danone Nutricia Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. Danone Nutricia Recent Developments
Table 53. Fresenius Kabi AG Company Information, Head Office, Market Area and Industry Position
Table 54. Fresenius Kabi AG Company Profile and Main Business
Table 55. Fresenius Kabi AG Oncology Nutrition Deals Models, Specifications, and Application
Table 56. Fresenius Kabi AG Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Fresenius Kabi AG Recent Developments
Table 58. FMC Corporation Company Information, Head Office, Market Area and Industry Position
Table 59. FMC Corporation Company Profile and Main Business
Table 60. FMC Corporation Oncology Nutrition Deals Models, Specifications, and Application
Table 61. FMC Corporation Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. FMC Corporation Recent Developments
Table 63. Global Health Products, Inc Company Information, Head Office, Market Area and Industry Position
Table 64. Global Health Products, Inc Company Profile and Main Business
Table 65. Global Health Products, Inc Oncology Nutrition Deals Models, Specifications, and Application
Table 66. Global Health Products, Inc Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. Global Health Products, Inc Recent Developments
Table 68. Koninklijke DSM N.V. Company Information, Head Office, Market Area and Industry Position
Table 69. Koninklijke DSM N.V. Company Profile and Main Business
Table 70. Koninklijke DSM N.V. Oncology Nutrition Deals Models, Specifications, and Application
Table 71. Koninklijke DSM N.V. Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Koninklijke DSM N.V. Recent Developments
Table 73. Mead Johnson & Company, LLC Company Information, Head Office, Market Area and Industry Position
Table 74. Mead Johnson & Company, LLC Company Profile and Main Business
Table 75. Mead Johnson & Company, LLC Oncology Nutrition Deals Models, Specifications, and Application
Table 76. Mead Johnson & Company, LLC Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Mead Johnson & Company, LLC Recent Developments
Table 78. Nestle Health Science Company Information, Head Office, Market Area and Industry Position
Table 79. Nestle Health Science Company Profile and Main Business
Table 80. Nestle Health Science Oncology Nutrition Deals Models, Specifications, and Application
Table 81. Nestle Health Science Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 82. Nestle Health Science Recent Developments
Table 83. Smartfish AS Company Information, Head Office, Market Area and Industry Position
Table 84. Smartfish AS Company Profile and Main Business
Table 85. Smartfish AS Oncology Nutrition Deals Models, Specifications, and Application
Table 86. Smartfish AS Oncology Nutrition Deals Revenue and Gross Margin, US$ Million, 2018-2023
Table 87. Smartfish AS Recent Developments
List of Figures
Figure 1. Oncology Nutrition Deals Picture
Figure 2. Global Oncology Nutrition Deals Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Oncology Nutrition Deals Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Oncology Nutrition Deals Market Share of Global, 2018-2029
Figure 5. Global Oncology Nutrition Deals Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Oncology Nutrition Deals Key Participants, Market Share, 2022
Figure 7. Oncology Nutrition Deals Industry Chain
Figure 8. Oncology Nutrition Deals Procurement Model
Figure 9. Oncology Nutrition Deals Sales Model
Figure 10. Oncology Nutrition Deals Sales Channels, Direct Sales, and Distribution
Figure 11. Enteral Nutrition
Figure 12. Parenteral Nutrition
Figure 13. By Type, Global Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Figure 14. By Type, Global Oncology Nutrition Deals Consumption Value Market Share, 2018-2029
Figure 15. Hospitals
Figure 16. Homecare
Figure 17. Specialty Clinics
Figure 18. By Application, Global Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Figure 19. By Application, Global Oncology Nutrition Deals Consumption Value Market Share, 2018-2029
Figure 20. By Region, Global Oncology Nutrition Deals Consumption Value Market Share, 2018-2029
Figure 21. North America Oncology Nutrition Deals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Oncology Nutrition Deals Consumption Value Market Share, 2022
Figure 23. Europe Oncology Nutrition Deals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Oncology Nutrition Deals Consumption Value Market Share, 2022
Figure 25. Asia Pacific Oncology Nutrition Deals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Oncology Nutrition Deals Consumption Value Market Share, 2022
Figure 27. South America Oncology Nutrition Deals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Oncology Nutrition Deals Consumption Value Market Share, 2022
Figure 29. Middle East & Africa Oncology Nutrition Deals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Figure 31. By Type, U.S. Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 32. By Application, U.S. Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 33. Europe Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Figure 34. By Type, Europe Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 35. By Application, Europe Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 36. China Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Figure 37. By Type, China Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 38. By Application, China Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 39. Japan Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Figure 40. By Type, Japan Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 41. By Application, Japan Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 42. South Korea Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Figure 43. By Type, South Korea Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 44. By Application, South Korea Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 45. Southeast Asia Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Figure 46. By Type, Southeast Asia Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 47. By Application, Southeast Asia Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 48. India Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Figure 49. By Type, India Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 50. By Application, India Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 51. Middle East & Africa Oncology Nutrition Deals Consumption Value, 2018-2029, US$ Million
Figure 52. By Type, Middle East & Africa Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 53. By Application, Middle East & Africa Oncology Nutrition Deals Consumption Value Market Share, 2022 VS 2029
Figure 54. Research Methodology
Figure 55. Breakdown of Primary Interviews
Figure 56. Bottom-up and Top-down Approaches
Figure 57. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|